United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
The Pharma Data
OCTOBER 27, 2020
Impairment of investment in privately-held company (2). Unrealized gain on investment in privately-held company (3). License-related fees (5). License-related fees (5). 2020.
Let's personalize your content